Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-105632
Filing Date
2025-11-04
Accepted
2025-11-04 08:15:31
Documents
7
Period of Report
2025-11-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0263824-6k_ascentage.htm 6-K 12665
2 PRESS RELEASE DATED NOVEMBER 3, 2025 ea026382401ex99-1_ascentage.htm EX-99.1 44064
3 PRESS RELEASE DATE NOVEMBER 3, 2025 ea026382401ex99-2_ascentage.htm EX-99.2 49373
4 ANNOUNCEMENT DATED NOVEMBER 4, 2025 ea026382401ex99-3_ascentage.htm EX-99.3 63261
5 GRAPHIC ex99-1_001.jpg GRAPHIC 10544
6 GRAPHIC ex99-2_001.jpg GRAPHIC 10626
7 GRAPHIC ex99-3_001.jpg GRAPHIC 18753
  Complete submission text file 0001213900-25-105632.txt   225962
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 251446550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)